Bispecific agonist boosts anti-tumour T cells via GITR

被引：0
|
作者：
Alexandra Flemming
机构：
[1] Nature Reviews Immunology,
来源：
Nature Reviews Immunology | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A bispecific molecule consisting of a PD1 antibody fused to a multimeric ligand for the costimulatory molecule GITR shows promising results in preclinical studies of solid tumours.
引用
收藏
页码：208 / 208
相关论文
共 50 条
  • [1] Bispecific agonist boosts anti-tumour T cells via GITR
    Flemming, Alexandra
    NATURE REVIEWS IMMUNOLOGY, 2022, 22 (04) : 208 - 208
  • [2] Turning on anti-tumour T cells via MTAP
    Bordon, Yvonne
    NATURE REVIEWS IMMUNOLOGY, 2023, 23 (11) : 703 - 703
  • [3] Turning on anti-tumour T cells via MTAP
    Yvonne Bordon
    Nature Reviews Immunology, 2023, 23 : 703 - 703
  • [4] Turning on anti-tumour T cells via MTAP
    Bordon, Yvonne
    NATURE REVIEWS IMMUNOLOGY, 2023,
  • [5] Targeted delivery of anti-tumour STING agonist
    Nesma El-Sayed Ibrahim
    Nature Reviews Bioengineering, 2023, 1 (8): : 544 - 544
  • [6] An anti-PD-1-GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy
    Chan, Sarah
    Belmar, Nicole
    Ho, Sun
    Rogers, Bryan
    Stickler, Marcia
    Graham, Michelle
    Lee, Eileen
    Tran, Ninian
    Zhang, Dong
    Gupta, Priyanka
    Sho, Mien
    MacDonough, Tracy
    Woolley, Andrew
    Kim, Han
    Zhang, Hong
    Liu, Wei
    Zheng, Pingping
    Derso, Zoltan
    Halliwill, Kyle
    Ceccarelli, Michele
    Rhodes, Susan
    Thakur, Archana
    Forsyth, Charles M.
    Xiong, Mengli
    Tan, Siu Sze
    Iyer, Ramesh
    Lake, Marc
    Digiammarino, Enrico
    Zhou, Li
    Bigelow, Lance
    Longenecker, Kenton
    Judge, Russell A.
    Liu, Cassie
    Trumble, Max
    Remis, Jonathan P.
    Fox, Melvin
    Cairns, Belinda
    Akamatsu, Yoshiko
    Hollenbaugh, Diane
    Harding, Fiona
    Alvarez, Hamsell M.
    NATURE CANCER, 2022, 3 (03) : 337 - +
  • [7] An anti-PD-1–GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy
    Sarah Chan
    Nicole Belmar
    Sun Ho
    Bryan Rogers
    Marcia Stickler
    Michelle Graham
    Eileen Lee
    Ninian Tran
    Dong Zhang
    Priyanka Gupta
    Mien Sho
    Tracy MacDonough
    Andrew Woolley
    Han Kim
    Hong Zhang
    Wei Liu
    Pingping Zheng
    Zoltan Dezso
    Kyle Halliwill
    Michele Ceccarelli
    Susan Rhodes
    Archana Thakur
    Charles M. Forsyth
    Mengli Xiong
    Siu Sze Tan
    Ramesh Iyer
    Marc Lake
    Enrico Digiammarino
    Li Zhou
    Lance Bigelow
    Kenton Longenecker
    Russell A. Judge
    Cassie Liu
    Max Trumble
    Jonathan P. Remis
    Melvin Fox
    Belinda Cairns
    Yoshiko Akamatsu
    Diane Hollenbaugh
    Fiona Harding
    Hamsell M. Alvarez
    Nature Cancer, 2022, 3 : 337 - 354
  • [8] Generation of anti-tumour effector T cells from naive T cells by stimulation with dendritic/tumour fusion cells
    Ishida, A.
    Tanaka, H.
    Hiura, T.
    Miura, S.
    Watanabe, S.
    Matsuyama, K.
    Kuriyama, H.
    Tanaka, J.
    Kagamu, H.
    Gejyo, F.
    Yoshizawa, H.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2007, 66 (05) : 546 - 554
  • [9] Targeting human cytotoxic T cells with (anti-tumour x anti-CD3) bispecific antibody against human colon cancer
    Alberts, J
    Glennie, M
    Smallwood, J
    EUROPEAN COUNCIL OF COLOPROCTOLOGY - ECCP BIENNIAL MEETING, 1997, : 21 - 22
  • [10] Bispecific trifunctional MoAb-opsonised lymphocytes for anti-tumour therapy
    Wiesneth, M
    Reinhardt, P
    Gronau, S
    Schmitt, M
    Atz, J
    Schrezenmeier, H
    Riechelmann, H
    BONE MARROW TRANSPLANTATION, 2006, 37 : S68 - S69
12345